Assessment of Health-Related Quality of Life in Adult Spinal Muscular Atrophy Under Nusinersen Treatment—A Pilot Study

5q-Spinal muscular atrophy (SMA) is a severely disabling inherited neuromuscular disease that progressively reduces the motor abilities of affected individuals. The approval of the antisense oligonucleotide nusinersen, which has been shown to improve motor function in adult SMA patients, changed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Thimm, Andreas, Brakemeier, Svenja, Kizina, Kathrin, Munoz Rosales, Juan, Stolte, Benjamin, Totzeck, Andreas, Deuschl, Cornelius, Kleinschnitz, Christoph, Hagenacker, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818760/
https://www.ncbi.nlm.nih.gov/pubmed/35140677
http://dx.doi.org/10.3389/fneur.2021.812063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818760/
https://www.ncbi.nlm.nih.gov/pubmed/35140677
http://dx.doi.org/10.3389/fneur.2021.812063

Ejemplares similares